- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Ashfield US Appoints New Senior Executives
Ashfield U.S., part of UDG Healthcare plc, global commercialization services for the pharmaceutical and healthcare industry, announced the appointment of Amy Van Sant as president of their new Medical Affairs business unit and Lee Ann Chaiken as senior VP of Ashfield’s Pharmacovigilance business.
Van Sant’s role will be focused on raising awareness of Ashfield’s Medical Affairs capabilities and executing the flexible and scalable programs clients require. She will be located in the Fort Washington, PA corporate headquarters of Ashfield U.S.
Chaiken has been appointed Senior VP of Ashfield’s Pharmacovigilance unit headquartered in Durham, NC, reporting directly to Van Sant.
Lykos Therapeutics Reshuffles Board of Directors Following FDA Rejection of Midomafetamine Capsules
January 15th 2025During the transition period, Lykos will work with a number of shareholders to secure financing for an additional Phase III trial of midomafetamine capsules for post-traumatic stress disorder.
